Micro-Tech (Nanjing) Co.,Ltd (SHA:688029)
China · Delayed Price · Currency is CNY 92.85
-0.27 (-0.29%)
Aug 22, 2025, 3:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Hemostasis and Closure | 921.37M | Log In | Log In | Log In | Log In | Upgrade |
Hemostasis and Closure Growth | 27.07% | Log In | Log In | Log In | Log In | Upgrade |
Endoscopic Mucosal Resection/Endoscopic Submucosal Dissection Class | 350.85M | Log In | Log In | Log In | Log In | Upgrade |
Endoscopic Mucosal Resection/Endoscopic Submucosal Dissection Class Growth | 37.94% | Log In | Log In | Log In | Log In | Upgrade |
Biopsy Class | 246.85M | Log In | Log In | Log In | Log In | Upgrade |
Biopsy Class Growth | -1.37% | Log In | Log In | Log In | Log In | Upgrade |
Expansion Class | 212.15M | Log In | Log In | Log In | Log In | Upgrade |
Expansion Class Growth | 13.56% | Log In | Log In | Log In | Log In | Upgrade |
Microwave Ablation Needle | 174.04M | Log In | Log In | Log In | Log In | Upgrade |
Microwave Ablation Needle Growth | 41.06% | Log In | Log In | Log In | Log In | Upgrade |
Endoscopic Retrograde Cholangiopancreatography Class | 172.87M | Log In | Log In | Log In | Log In | Upgrade |
Endoscopic Retrograde Cholangiopancreatography Class Growth | 57.60% | Log In | Log In | Log In | Log In | Upgrade |
Visual Product | 97.44M | Log In | Log In | Log In | Log In | Upgrade |
Visual Product Growth | -48.78% | Log In | Log In | Log In | Log In | Upgrade |
Proxy | 89.77M | Log In | Log In | Log In | Log In | Upgrade |
Proxy Growth | 67.74% | Log In | Log In | Log In | Log In | Upgrade |
Endoscopic Ultrasonography/Endobronchial Ultrasound Class | 43.44M | Log In | Log In | Log In | Log In | Upgrade |
Endoscopic Ultrasonography/Endobronchial Ultrasound Class Growth | 82.38% | Log In | Log In | Log In | Log In | Upgrade |
Other | 102.70M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 63.13% | Log In | Log In | Log In | Log In | Upgrade |
Tumor Ablation Device | - | Log In | Log In | Log In | Log In | Upgrade |
Tumor Ablation Device Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 1.35B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 18.21% | Log In | Log In | Log In | Log In | Upgrade |
International | 1.04B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | 25.80% | Log In | Log In | Log In | Log In | Upgrade |